HIF1A and acute lymphoblastic leukemia: 2ME2, a natural estradiol metabolite, has been shown to inhibit the nuclear accumulation and activity of HIF1α in an oxygen- and proteasome-independent manner [28], while Afinitor, an mTOR inhibitor, has been shown to reduce the expression of HIF1α and restore chemosensitivity in ALL cells [29].